PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES OF INTRAVENOUS FENOLDOPAM, A DOPAMINE1-RECEPTOR AGONIST, IN HYPERTENSIVE PATIENTS

被引:54
作者
WEBER, RR
MCCOY, CE
ZIEMNIAK, JA
FREDERICKSON, ED
GOLDBERG, LI
MURPHY, MB
机构
[1] UNIV CHICAGO,DEPT PHARMACOL & PHYSIOL SCI,COMM CLIN PHARMACOL,947 E 58TH ST,CHICAGO,IL 60637
[2] UNIV CHICAGO,DEPT MED,CHICAGO,IL 60637
[3] SK&F LABS,PHILADELPHIA,PA 19101
关键词
D O I
10.1111/j.1365-2125.1988.tb03276.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:17 / 21
页数:5
相关论文
共 10 条
[1]   THE EFFECT OF FENOLDOPAM, A DOPAMINERGIC AGONIST, ON RENAL HEMODYNAMICS [J].
ALLISON, NL ;
DUBB, JW ;
ZIEMNIAK, JA ;
ALEXANDER, F ;
STOTE, RM .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (03) :282-288
[2]  
BOPPANA VK, 1984, J CHROMATOGR, V317, P463, DOI 10.1016/S0021-9673(01)91686-3
[3]   SELECTIVE PERIPHERAL DOPAMINE-1 RECEPTOR STIMULATION WITH FENOLDOPAM IN HUMAN ESSENTIAL-HYPERTENSION [J].
CAREY, RM ;
STOTE, RM ;
DUBB, JW ;
TOWNSEND, LH ;
ROSE, CE ;
KAISER, DL .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (06) :2198-2207
[5]  
HAHN RA, 1982, J PHARMACOL EXP THER, V223, P305
[6]   THE ACTION OF A DOPAMINE (DA1) RECEPTOR AGONIST, FENOLDOPAM IN HUMAN VASCULATURE INVIVO AND INVITRO [J].
HUGHES, A ;
THOM, S ;
MARTIN, G ;
REDMAN, D ;
HASAN, S ;
SEVER, P .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (05) :535-540
[7]  
MCCOY C, 1985, HYPERTENSION, V7, P848
[8]   A NEW ORAL RENAL VASODILATOR, FENOLDOPAM [J].
STOTE, RM ;
DUBB, JW ;
FAMILIAR, RG ;
ERB, BB ;
ALEXANDER, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (03) :309-315
[9]   IMMEDIATE HEMODYNAMIC-EFFECTS OF A DOPAMINE-RECEPTOR AGONIST (FENOLDOPAM) IN PATIENTS WITH ESSENTIAL-HYPERTENSION [J].
VENTURA, HO ;
MESSERLI, FH ;
FROHLICH, ED ;
KOBRIN, I ;
OIGMAN, W ;
DUNN, FG ;
CAREY, RM .
CIRCULATION, 1984, 69 (06) :1142-1145
[10]  
ZIEMNIAK J, 1985, CLIN PHARMACOL THER, V37, P240